< Back to latest news & events

COVID-19

IP considerations in COVID-19 vaccine development: tensions and tools

June 2020

Development of COVID-19 vaccines will produce valuable IP that could be protected by patents.

However, given that a patent application is not published until about 18 months from its initial filing date, we cannot yet see what kinds of inventions are sought to be covered, who is filing patents, and where patents are being filed to protect COVID-19 related inventions. Given the nature of the pandemic affecting most of the world’s population, its rapid spread and severe complications it causes, some may question whether any IP developed in this area should be subject to protection by private parties to begin with.

HGF Partner Dr Leena Contarino and Senior Patent Attorney Ellie Purnell discuss the perceived tension between patent protection and information sharing at a time of need for collaboration and speed, and suggest that, as evidenced by the Ebola vaccine campaign, patent protection, information sharing, and collaboration are not necessarily mutually exclusive endeavours.

They propose that while some simplified licensing schemes that could be tools to speed up sharing, such as patent pooling initiatives modelled by the telecom and electronics industry are still facing resistance among some pharma companies, development of a better information sharing platform for vaccine technologies could serve as one way to speed up collaborations at time of crises. You can read more about COVID-19 licensing challenges here.

Click here to read the full article prepared by HGF Partner Dr Leena Contarino and Senior Patent Attorney Ellie Purnell.

Latest updates

Paul Sanderson

We are sorry to announce that Paul Sanderson is leaving HGF on 30 September 2021. Paul joined HGF in February 2002 to establish HGF Law, becoming CEO of the wider …

Read article
Event - 7th October 2021

The Business of Science Conference 2021

HGF is sponsoring The Business of Science Conference 2021 on 7th October. Science and the commercialisation of science continues to be fundamental to the economic growth of the UK and …

Event details

IAM Strategy 300 2021

IAM Strategy 300 Global Leaders guide has been published and HGF is delighted to have 4 Partners listed. The guide draws from the worlds of private practice, consulting and other …

Read article